AAAAAA
Results: 1-25/41
Authors:
BORAWSKI J
RYDZEWSKI A
AZZADIN A
BUCZKO W
MYSLIWIEC M
Citation: J. Borawski et al., MODULATION OF HEMATOPOIESIS BY KETANSERIN IN ERYTHROPOIETIN-TREATED UREMIC PATIENTS - EVIDENCE FROM PLATELET STUDIES, Platelets, 9(1), 1998, pp. 31-35
Authors:
MALYSZKO J
MALYSZKO JS
MYSLIWIEC M
Citation: J. Malyszko et al., TISSUE FACTOR PATHWAY INHIBITOR AND TISSUE FACTOR IN HD AND CAPD, Nephrology, dialysis, transplantation, 13(9), 1998, pp. 2424-2426
Authors:
MALYSZKO J
MALYSZKO JS
MYSLIWIEC M
Citation: J. Malyszko et al., TISSUE FACTOR AND TISSUE FACTOR PATHWAY INHIBITOR IN ACUTE AND CHRONIC-RENAL-FAILURE, Thrombosis and haemostasis, 80(4), 1998, pp. 722-724
Authors:
PAWLAK D
ADAMKIEWICZ M
MALYSZKO J
TAKADA A
MYSLIWIEC M
BUCZKO W
Citation: D. Pawlak et al., VASCULAR AND CARDIAC EFFECTS OF DV-7028, A SELECTIVE, 5-HT2-RECEPTOR ANTAGONIST IN RATS, Journal of cardiovascular pharmacology, 32(2), 1998, pp. 266-273
Authors:
PAWLAK D
PAWLAK K
CHABIELSKA E
MALYSZKO J
TAKADA A
MYSLIWIEC M
BUCZKO W
Citation: D. Pawlak et al., A POTENT 5-HYDROXYTRYPTAMINE RECEPTOR (5-HT2A) ANTAGONIST, DV-7028, DELAYS ARTERIAL THROMBOSIS DEVELOPMENT IN RATS, Thrombosis research, 90(6), 1998, pp. 259-270
Authors:
BORAWSKI J
RYDZEWSKI A
PAWLAK K
AZZADIN A
BUCZKO W
MYSLIWIEC M
Citation: J. Borawski et al., LONG-TERM EFFECTS OF ERYTHROPOIETIN ON PLATELET SEROTONIN STORAGE ANDPLATELET-AGGREGATION IN HEMODIALYSIS-PATIENTS WITH REFERENCE TO KETANSERIN TREATMENT, Thrombosis research, 90(4), 1998, pp. 171-180
Authors:
MALYSZKO JS
MALYSZKO J
PAWLAK D
BUCZKO W
MYSLIWIEC M
Citation: Js. Malyszko et al., HEMOSTASIS, PLATELET FUNCTIONS, SEROTONIN AND SERUM-LIPIDS DURING OMEGA-3-FATTY-ACID TREATMENT IN PATIENTS WITH GLOMERULONEPHRITIS, Nephron, 80(1), 1998, pp. 94-96
Authors:
MYSLIWIEC M
Citation: M. Mysliwiec, VASCULAR ACCESS THROMBOSIS - WHAT ARE THE POSSIBILITIES OF INTERVENTION, Nephrology, dialysis, transplantation, 12(5), 1997, pp. 876-878
Authors:
MAZERSKA M
RYDZEWSKI A
POPLAWSKA A
KINALSKA I
MYSLIWIEC M
Citation: M. Mazerska et al., FIBRINOLYTIC-ACTIVITY IN TYPE-II DIABETIC-PATIENTS WITH MICROALBUMINURIA - EFFECTS OF ANTIHYPERTENSIVE TREATMENT, Thrombosis and haemostasis, 1997, pp. 611-611
Authors:
MALYSZKO J
MALYSZKO J
PAWLAK K
MYSLIWIEC M
Citation: J. Malyszko et al., HEMOSTASIS, FIBRINOLYSIS, PLATELET-FUNCTION, AND SERUM-LIPIDS IN GLOMERULONEPHRITIS (GN) AND NEPHROTIC SYNDROME (NS), Thrombosis and haemostasis, 1997, pp. 783-783
Authors:
AZZADIN A
POPLAWSKI A
CHABIELSKA E
MALYSZKO J
PAWLAK R
MYSLIWIEC M
BUCZKO W
Citation: A. Azzadin et al., THE EFFECTS OF L-CARNITINE ON ANEMIA IN UREMIC RATS, Thrombosis and haemostasis, 1997, pp. 1869-1869
Authors:
RYDZEWSKI A
MALYSZKO J
BORAWSKI J
PAWLAK D
AZZADIN A
BUCZKO W
MYSLIWIEC M
Citation: A. Rydzewski et al., ALTERED CIRCADIAN-RHYTHM OF PLATELET-AGGREGATION IN HEMODIALYZED PATIENTS, Nephron, 77(3), 1997, pp. 365-367
Authors:
PAWLAK D
PAWLAK J
MALYSZKO J
CHABIELSKA E
MYSLIWIEC M
ZABLOTNA B
TAKADA A
BUCZKO W
Citation: D. Pawlak et al., ESTIMATION OF ANTITHROMBOTIC EFFECT OF DV-7028, A SELECTIVE 5-HT2 RECEPTOR ANTAGONIST, IN ARTERIAL AND VENOUS THROMBOSIS IN RATS, Naunyn-Schmiedeberg's archives of pharmacology, 356(4), 1997, pp. 215-215
Authors:
GORSKI J
HERMENS WT
BORAWSKI J
MYSLIWIEC M
GLATZ JFC
Citation: J. Gorski et al., INCREASED FATTY-ACID-BINDING PROTEIN-CONCENTRATION IN PLASMA OF PATIENTS WITH CHRONIC-RENAL-FAILURE (VOL 43, PG 193, 1997), Clinical chemistry, 43(4), 1997, pp. 692-692
Authors:
GORSKI J
HERMENS WT
BORAWSKI J
MYSLIWIEC M
GLATZ JFC
Citation: J. Gorski et al., INCREASED FATTY-ACID-BINDING PROTEIN-CONCENTRATION IN PLASMA OF PATIENTS WITH CHRONIC-RENAL-FAILURE, Clinical chemistry, 43(1), 1997, pp. 193-195
Authors:
MALYSZKO JS
MALYSZKO J
PAWLAK K
MYSLIWIEC M
Citation: Js. Malyszko et al., ERYTHROPOIETIN AND UREMIC PLATELET-AGGREGATION IN-VIVO AND IN-VITRO, International journal of clinical & laboratory research, 26(3), 1996, pp. 199-202
Authors:
BORAWSKI J
RYDZEWSKI A
MAZERSKA M
KALINOWSKI M
PAWLAK K
MYSLIWIEC M
Citation: J. Borawski et al., INVERSE RELATIONSHIPS BETWEEN HEMOGLOBIN AND RISTOCETIN-INDUCED PLATELET-AGGREGATION IN HEMODIALYSIS-PATIENTS UNDER ERYTHROPOIETIN THERAPY, Nephrology, dialysis, transplantation, 11(12), 1996, pp. 2444-2448
Authors:
BORAWSKI J
MAZERSKA M
RYDZEWSKI A
PAWLAK K
ROWINSKI M
MYSLIWIEC M
Citation: J. Borawski et al., KETANSERIN - A NEW PERSPECTIVE IN POSTTRANSPLANT ERYTHROCYTOSIS, Clinical transplantation, 10(1), 1996, pp. 63-66
Authors:
BORAWSKI J
MAZERSKA M
PAWLAK K
MYSLIWIEC M
Citation: J. Borawski et al., KETANSERIN AND ERYTHROPOIESIS IN HEMODIALYSIS-PATIENTS WITH POLYCYSTIC KIDNEYS, American journal of nephrology, 16(5), 1996, pp. 451-452
Authors:
MALYSZKO J
MALYSZKO JS
PAWLAK D
PAWLAK K
BUCZKO W
MYSLIWIEC M
Citation: J. Malyszko et al., HEMOSTASIS, PLATELET-FUNCTION AND SEROTONIN IN ACUTE AND CHRONIC-RENAL-FAILURE, Thrombosis research, 83(5), 1996, pp. 351-361
Authors:
MYSLIWIEC J
AZZADIN A
CHABIELSKA E
TAKADA A
MYSLIWIEC M
BUCZKO W
Citation: J. Mysliwiec et al., THE EFFECT OF TACROLIMUS (FK506) AND CYCLOSPORINE-A (CYA) ON PERIPHERAL SEROTONERGIC MECHANISMS IN UREMIC RATS, Thrombosis research, 83(2), 1996, pp. 175-181
Authors:
PAWLAK D
MALYSZKO J
MALYSZKO JS
PAWLAK K
BUCZKO W
MYSLIWIEC M
Citation: D. Pawlak et al., PERIPHERAL SEROTONERGIC SYSTEM IN UREMIA, Thrombosis research, 83(2), 1996, pp. 189-194
Authors:
MALYSZKO JS
MALYSZKO J
PAWLAK K
MYSLIWIEC M
TAKADA Y
TAKADA A
Citation: Js. Malyszko et al., EFFECTS OF AZATHIOPRINE AND MIZORIBINE ON AGGREGATION OF NORMAL AND UREMIC PLATELETS, Transplantation proceedings, 28(6), 1996, pp. 3488-3489
Authors:
MALYSZKO J
PAWLAK D
PAWLAK K
MALYSZKO JS
BUCZKO W
AZZUDIN A
MYSLIWIEC M
Citation: J. Malyszko et al., PLATELET-AGGREGATION AND PERIPHERAL SEROTONERGIC SYSTEM IN KIDNEY-TRANSPLANT RECIPIENTS TREATED WITH CYCLOSPORINE, Transplantation proceedings, 28(3), 1996, pp. 1954-1957
THE COAGULO-LYTIC SYSTEM AND ENDOTHELIAL FUNCTION IN CYCLOSPORINE-TREATED KIDNEY ALLOGRAFT RECIPIENT
Authors:
MALYSZKO J
MALYSZKO JS
PAWLAK K
MYSLIWIEC M
Citation: J. Malyszko et al., THE COAGULO-LYTIC SYSTEM AND ENDOTHELIAL FUNCTION IN CYCLOSPORINE-TREATED KIDNEY ALLOGRAFT RECIPIENT, Transplantation, 62(6), 1996, pp. 828-830